Piramal Pharma Limited

258.45

INR
-1.25(-0.48%)
As of November 14, 2024 10:00:00 AM

About Piramal Pharma Limited

Piramal Pharma Limited operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the spectrum of the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; complex hospital generics business which offers inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain and anesthesia drugs, and other generic and specialty products; and India consumer healthcare business comprising analgesics, skin care, vitamin/mineral supplement, kids' wellness, digestives, women's health, and hygiene and protection. The company was incorporated in 2020 and is based in Mumbai, India.

RevenueLast 12 months
NA
+NA YoY
EBITDALast 12 months
NA
Price to Sales RatioTTM
4.07x
Operating MarginLast 12 months
6.66
+350% quarterly YoY
Market Cap
35433.48 CrINR
Employees
6719
CEO
Mr. Peter Daniel DeYoung
Website

Piramal Pharma Limited

258.45

INR
-1.25(-0.48%)
As of November 14, 2024 10:00:00 AM

About Piramal Pharma Limited

Piramal Pharma Limited operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the spectrum of the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; complex hospital generics business which offers inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain and anesthesia drugs, and other generic and specialty products; and India consumer healthcare business comprising analgesics, skin care, vitamin/mineral supplement, kids' wellness, digestives, women's health, and hygiene and protection. The company was incorporated in 2020 and is based in Mumbai, India.

RevenueLast 12 months
NA
+NA YoY
EBITDALast 12 months
NA
Price to Sales RatioTTM
4.07x
Operating MarginLast 12 months
6.66
+350% quarterly YoY
Market Cap
35433.48 CrINR
Employees
6719
CEO
Mr. Peter Daniel DeYoung
Website